Limitations of currently available Chagas disease chemotherapy

Revista Espanola de Quimioterapia

Volumn 25, Issue 1, 2012, Pages 1-3

  Murcia, Laura ^a   Carrilero, Bartolomé ^a   Segovia, Manuel ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BENZNIDAZOLE; ERGOSTEROL; ITRACONAZOLE; KETOCONAZOLE; NIFURTIMOX; POSACONAZOLE;

ANOREXIA; ARTHRITIS; ARTHROPATHY; ASTHENIA; AUSTRALIA; CANADA; CHAGAS DISEASE; CHEMOTHERAPY; DISEASE TRANSMISSION; DISORIENTATION; DRUG TOLERANCE; DYSPHASIA; EARLY DIAGNOSIS; EDITORIAL; EPIGASTRIC ARTERY; FEVER; HEADACHE; HEALTH SURVEY; HUMAN; IMMIGRATION; INSOMNIA; KIDNEY FAILURE; MORTALITY; MUSCLE SPASM; NAUSEA; NEURITIS; POLYMERASE CHAIN REACTION; REMISSION; SEIZURE; SENSITIVITY AND SPECIFICITY; SEROLOGY; SIDE EFFECT; SKIN ALLERGY; SPAIN; TROPICAL MEDICINE; TRYPANOSOMA CRUZI; UNITED STATES; VERTIGO; VOMITING; WEIGHT REDUCTION;

CHAGAS DISEASE; HUMANS; NIFURTIMOX; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 84859645280     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (16)

1. Chagas C. Nouvelle espèce de trypanosomiase humaine. Bull Soc Pathol Exot 1996; 2: 304-307.
2. Carrilero B, Quesada JJ, Alfayate S, Segovia M. Congenital Chagas disease in a newborn of a Bolivian mother [in Spanish]. Enferm Infecc Microbiol Clin 2009; 27: 486-487.
3. Muñoz J, Portús M, M. Corachan, Fumadó V, Gascon J. Congenital Trypanosoma cruzi infection in a non-endemic area. Trans R Soc Trop Med Hyg 2007; 101: 1161-1162.
4. Gascón J, Bern C, Pinazo MJ. Chagas disease in Spain, the United Stated and other non-endemic countries. Acta Trop 2010;115: 22-7.
5. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD, et al. Control of neglected tropical diseases. N Engl J Med 2007; 357: 1018-1027.
6. Urbina JA. Ergosterol biosynthesis and drug development for Chagas disease. Mem Inst Oswaldo Cruz 2009; 104: 311-8.
7. de Andrade AL, Zicker F, de Oliveira RM, Almeida Silva S, Luquetti A, Travassos LR, et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996; 348: 1407-1413.
8. Sosa Estani S, Segura EL, Ruiz AM, Velazquez E, Porcel BM, Yampotis C. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. Am J Trop Med Hyg 1998; 59: 526-529.
9. Schijman AG, Altcheh J, Burgos JM, Biancardi M, Bisio M, Levin MJ, et al. Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction. J Antimicrob Chemother 2003; 52: 441-449.
10. Pérez-Molina JA, Pérez-Ayala A, Moreno S, Fernández-González MC, Zamora J, López-Velez R. Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis. J Antimicrob Chemother 2009; 64: 1139-1147.
11. Murcia L, Carrilero B, Muñoz MJ, Iborra MA, Segovia M. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country. Journal of Antimicrobial Chemotherapy 2010; 65:1759-1764.
12. Carrilero B, Murcia L, Martínez-Lage L, Segovia M. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country. Rev Esp Quimioter 2011; 24:123-126.
13. Murcia L, Carrilero B, Segovia M. Nifurtimoxchemotherapy: collateral effects in treated Trypanosoma cruzi infected patients.Rev Esp Quimioter 2012; 25: 74-75.
14. Rodrigues J. Present situation and new strategies for Chagaśdisease chemotherapy - a proposal. Mem Inst Oswaldo Cruz 2009, 104: 549-554.
15. Gerpe A, Odreman-Nunez I, Draper P, Boiani L, Urbina J A, Gonzalez M, et al. Heteroallyl-containing 5-nitrofuranes as new anti- Trypanosoma cruzi agents with a dual mechanism of action. Bioorg Med Chem 2008, 16: 569-577.
16. Flechas ID, Cuellar A, Cucunubá ZM, Rosas F, Velasco V, Steindel M, et al. Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients. BMC Infect Dis 2009; 9:186.